Severe asthma: Lessons from the Severe Asthma Research Program

Journal of Allergy and Clinical Immunology

Volumn 119, Issue 1, 2007, Pages 14-21

  Wenzel, Sally E ^a   Busse, William W ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

allergy; Asthma; corticosteroids; phenotypes

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CORTICOSTEROID; LIPOXIN; OXIDIZING AGENT; SALBUTAMOL;

ALLERGIC ASTHMA; BRONCHOSCOPY; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; GENETICS; HEALTH PROGRAM; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; LUNG; LUNG MECHANICS; MEDICAL RESEARCH; MEDICAL SOCIETY; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION; REVIEW; RISK FACTOR; SAMPLE;

ASTHMA; BRONCHOSCOPY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); PHENOTYPE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 33846017302     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2006.10.025     Document Type: Review

References (43)

1. Jarvis D., and Burney P. Epidemiology of asthma. In: Busse W.W., and Holgate S.T. (Eds). Asthma and rhinitis (2000), Blackwell Scientific, London 17-32
2. Lim S., Jatakanon A., John M., Gilbey T., O'Connor B.J., Chung K.F., et al. Effect of inhaled budesonide on lung function and airway inflammation: assessment by various inflammatory markers in mild asthma. Am J Respir Crit Care Med 159 (1999) 22-30
3. Wilson J.W., Djukanovic R., Howarth P.H., and Holgate S.T. Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma. Am J Respir Crit Care Med 149 (1994) 86-90
4. Booth H., Richmond I., Ward C., Gardiner P.V., Harkawat R., and Walters E.H. Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma. Am J Respir Crit Care Med 152 (1995) 45-52
5. Barnes P.J., and Woolcock A.J. Difficult asthma. Eur Respir J 12 (1998) 1209-1218
6. Barnes P.J., Jonsson B., and Klim J.B. The costs of asthma. Eur Respir J 9 (1996) 636-642
7. Moore B.B., Sullivan S.D., and Weiss K.B. Epidemiology and socioeconomic impact of severe asthma. In: Szefler S.J., and Leung D.Y.M. (Eds). Severe asthma (1996), Marcell Dekker, New York 1-34
8. Busse W., Banks-Schlegel S., and Wenzel S.E. Pathophysiology of severe asthma. J Allergy Clin Immunol 106 (2000) 1033-1042
9. National Asthma Education and Prevention Program Expert Panel report 2: guidelines for the diagnosis and management of asthma: publication #97-4051 (NAEPP). US Department of Health & Human Services; 1997.
10. Global Initiative for Asthma: global strategy for asthma management and prevention (GINA) (2002), National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda (MD)
11. Miller M.K., Johnson C., Miller D.P., Deniz Y., Bleecker E.R., and Wenzel S.E. Severity assessment in asthma: an evolving concept. J Allergy Clin Immunol 116 (2005) 990-995
12. Wenzel SE, Fahy JV, Irvin CG, Peters SP, Spector S, Szefler SJ. Proceedings of the ATS Workshop on Refractory Asthma: current understanding, recommendations and unanswered questions. Am J Respir Crit Care Med 2000;162:2341-51.
13. Moore W.C., Bleecker E.R., Curran-Everett D., Erzurum S.C., Ameredes B.T., Bacharier L., et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol (2007) In press
14. Chanez P, Wenzel SE, Anderson G. Severe asthma: What are the important questions? J Allergy Clin Immunol 2007. In press.
15. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J 22 (2003) 470-477
16. ten Brinke A., Grootendorst D.C., Schmidt J.T., De Bruine F.T., van Buchem M.A., Sterk P.J., et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 109 (2002) 621-626
17. Dixon A.E., Kaminsky D.A., Holbrook J.T., Wise R.A., Shade D.M., and Irvin C.G. Allergic rhinitis and sinusitis in asthma: differential effects on symptoms and pulmonary function. Chest 130 (2006) 429-435
18. Simpson JL, Grissell TV, Douwes J, Scott RJ, Boyle MJ, Gibson PG. Innate immune activation in neutrophilic asthma and bronchiectasis. Thorax 2006 Jul 14; [Epub ahead of print].
19. Talbot T.R., Hartert T.V., Mitchel E., Halasa N.B., Arbogast P.G., Poehling K.A., et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 352 (2005) 2082-2090
20. Halloum AM PL, Blum S, Menon L. Impact of increasing body mass index on pulmonary function in asthma. Proceedings of the American Thoracic Society 2005;2:101-8.
21. Higgins P.S., Wakefield D., and Cloutier M.M. Risk factors for asthma and asthma severity in nonurban children in Connecticut. Chest 128 (2005) 3846-3853
22. Gupta R.S., Carrion-Carire V., and Weiss K.B. The widening black/white gap in asthma hospitalizations and mortality. J Allergy Clin Immunol 117 (2006) 351-358
23. ten Brinke A., Sterk P.J., Masclee A.A., Spinhoven P., Schmidt J.T., Zwinderman A.H., et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 26 (2005) 812-818
24. Miranda C., Busacker A., Balzar S., Trudeau J., and Wenzel S.E. Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol 113 (2004) 101-108
25. ten Brinke A., van Dissel J.T., Sterk P.J., Zwinderman A.H., Rabe K.F., and Bel E.H. Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. J Allergy Clin Immunol 107 (2001) 449-454
26. Fitzpatrick A.M., Gaston B., Erzurum S., and Teague W. Features of severe asthma in school age children: atopy and increased exhaled nitric oxide. J Allergy Clin Immunol 118 (2006) 1218-1225
27. Comhair S.A., Ricci K.S., Arroliga M., Lara A.R., Dweik R.A., Song W., et al. Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. Am J Respir Crit Care Med 172 (2005) 306-313
28. Balzar S., Chu H.W., Strand M., and Wenzel S. Relationship of small airway chymase-positive mast cells and lung function in severe asthma. Am J Respir Crit Care Med 171 (2005) 431-439
29. Kotaru C., Schoonover K.J., Trudeau J.B., Huynh M.L., Zhou X., Hu H., et al. Regional fibroblast heterogeneity in the lung: implications for remodeling. Am J Respir Crit Care Med 173 (2006) 1208-1215
30. Hew M., Bhavsar P., Torrego A., Meah S., Khorasani N., Barnes P.J., et al. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 174 (2006) 134-141
31. Wenzel S.E., Szefler S.J., Leung D.Y.M., Sloan S.I., Rex M.D., and Martin R.J. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 156 (1997) 737-743
32. Barnes P.J., Ito K., and Adcock I.M. Corticosteroid resistance in chronic obstructive pulmonary disease: inactivation of histone deacetylase. Lancet 363 (2004) 731-733
33. Matthews J.G., Ito K., Barnes P.J., and Adcock I.M. Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J Allergy Clin Immunol 113 (2004) 1100-1108
34. Vachier I., Bonnans C., Chavis C., Farce M., Godard P., Bousquet J., et al. Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound. J Allergy Clin Immunol 115 (2005) 55-60
35. Levy B.D., Bonnans C., Silverman E.S., Palmer L.J., Marigowda G., and Israel E. Diminished lipoxin biosynthesis in severe asthma. Am J Respir Crit Care Med 172 (2005) 824-830
36. Castro M., Bloch S.R., Jenkerson M.V., DeMartino S., Hamilos D.L., Cochran R.B., et al. Asthma exacerbations after glucocorticoid withdrawal reflects T cell recruitment to the airway. Am J Respir Crit Care Med 169 (2004) 842-849
37. Moore W, Calhoun W, Castro M, Chung F, Erzurum S, Jarjour N, et al. Safety of investigative bronchoscopy in severe asthma. Proceedings of the American Thoracic Society 2006;3:A16.
38. Wenzel S.E., Schwartz L.B., Langmack E.L., Halliday J.L., Trudeau J.B., Gibbs R.L., et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160 (1999) 1001-1008
39. Simpson J.L., Scott R.J., Boyle M.J., and Gibson P.G. Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. Am J Respir Crit Care Med 172 (2005) 559-565
40. Awadh N., Muller N.L., Park C.S., Abboud R.T., and FitzGerald J.M. Airway wall thickness in patients with near fatal asthma and control groups: assessment with high resolution computed tomographic scanning. Thorax 53 (1998) 248-253
41. Niimi A., Matsumoto H., Takemura M., Ueda T., Chin K., and Mishima M. Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med 168 (2003) 983-988
42. Kotaru C WS, Castro M, Busse WW, Hoffman E, Everett D, Newell JD. Air trapping on CT predicts severity of asthma, symptoms and ICU admissions. Proceedings of the American Thoracic Society 2006;3:A16.
43. Wenzel S., Balzar S., Ampelford E., Hawkins G.A., Busse W.W., Calhoun W.J., et al. IL-4Rα mutations are associated with asthma exacerbations and mast cell/IgE expression. Am J Respir Crit Care Med (2007) In press